AbbVie Stock Will Hit $300 on This Date
1 Articles
1 Articles
AbbVie Stock Will Hit $300 on This Date
The post AbbVie Stock Will Hit $300 on This Date appeared first on 24/7 Wall St.. AbbVie (NYSE:ABBV) has quietly become one of healthcare’s most underrated growth stories. CEO Robert A. Michael told investors after Q1, “We are off to an excellent start in 2026, with first-quarter results exceeding our expectations.” The numbers back him up. Immunology revenue hit $7.29 billion, with Skyrizi up 30.9% and Rinvoq up 23.3%. Yet shares trade at just …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
